Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Subject Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Program
    • Feedback
    • Reprints
    • Impact Factor
  • ASN Kidney News
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Subject Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Program
    • Feedback
    • Reprints
    • Impact Factor
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
CLINICAL EPIDEMIOLOGY
You have accessRestricted Access

Carotid Endarterectomy Benefits Patients with CKD and Symptomatic High-Grade Stenosis

Anna Mathew, Michael Eliasziw, P.J. Devereaux, Jose G. Merino, Henry J.M. Barnett, Amit X. Garg and for the North American Symptomatic Carotid Endarterectomy Trial (NASCET) Collaborators
JASN January 2010, 21 (1) 145-152; DOI: https://doi.org/10.1681/ASN.2009030287
Anna Mathew
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Eliasziw
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P.J. Devereaux
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jose G. Merino
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henry J.M. Barnett
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amit X. Garg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Cumulative proportion of ipsilateral stroke from Kaplan-Meier analyses by degree of ICA stenosis, eGFR level (ml/min per 1.73 m2), and treatment group is shown.

Tables

  • Figures
  • Additional Files
    • View popup
    Table 1.

    Comparison of baseline patient characteristics

    CharacteristiceGFR <60(n = 524)eGFR ≥60(n = 966)P
    Age<0.001
        >65 yr (%)73.344.4
        mean (range)69 (38 to 89)64 (31 to 85)
    Female gender (%)37.627.1<0.001
    Black race (%)1.53.80.01
    Qualifying (presenting) ischemic event (%)
        stroke (not TIA)41.238.80.37
        hemispheric (not retinal)72.171.30.74
    History of (%)
        TIA or stroke within past 6 moa54.855.70.73
        hypertension73.754.3<0.001
        diabetes22.521.00.50
        MI24.018.00.006
        CHF3.82.00.03
        arrhythmia4.25.30.36
        hyperlipidemia35.734.50.64
        intermittent claudication17.013.80.10
    Smoking within past 12 mo (%)34.550.2<0.001
    Systolic BP >160 mmHg (%)23.516.70.001
    Diastolic BP >90 mmHg (%)13.012.00.59
    Glucose >7 mmol/L (>126 mg/dl) (%)20.021.20.59
    Degree of ICA stenosis 70 to 99% (%)41.444.50.25
    eGFR (ml/min per 1.73 m2; mean [range])49 (19 to 60)79 (60 to 153)–
    Serum creatinine (μmol/L; mean [range])127 (86 to 292)87 (39 to 133)–
    Serum creatinine (mg/dl; mean [range])1.5 (0.9 to 3.3)1.0 (0.4 to 1.5)–
    • Characteristics were compared using a χ2 test. TIA, transient ischemic attack; ICA, internal carotid artery stenosis; MI, myocardial infarction.

    • ↵aIn addition to the qualifying (presenting) event.

    • View popup
    Table 2.

    Two-year risks for outcomes by treatment and CKD status (eGFR, ml/min per 1.73 m2) in patients with high-grade internal carotid artery stenosis (70 to 99%)

    ParameterMedical Risk (%)(n = 126)a(n = 197)bSurgical Risk (%)(n = 91)a(n = 233)bRRR (%)Absolute Risk Difference (%; 95% CI)PInteraction Test (P)
    Risk DifferenceRRR
    Ipsilateral strokec
        eGFR <6031.65.682.326.0 (15.1 to 36.8)<0.0010.0180.051
        eGFR ≥6019.39.550.89.8 (1.9 to 17.7)0.047
    Death (any cause)
        eGFR <609.49.7−3.2−0.3 (−11.1 to 10.5)0.940.830.78
        eGFR ≥605.94.916.91.0 (−4.4 to 6.4)0.59
    Any stroke, MI, or vascular death
        eGFR <6040.717.557.023.2 (9.6 to 36.7)0.0160.070.26
        eGFR ≥6023.015.034.88.0 (−1.0 to 17.0)0.13
    • Medical and surgical groups were compared using a log-rank test. RRR, relative risk reduction.

    • ↵aeGFR <60 ml/min per 1.73 m2.

    • ↵beGFR ≥60 ml/min per 1.73 m2.

    • ↵cTo provide a more conservative estimate of the benefits of endarterectomy, the outcome “ipsilateral stroke” includes any stroke and any death within 32 d of randomization (30 d postoperatively; median time from randomization to surgery was 2 d).

    • View popup
    Table 3.

    Two-year risks of outcomes by treatment and CKD status (eGFR, ml/min per 1.73 m2) in patients with moderate-grade ICA stenosis (50 to 69%)

    ParameterMedical Risk (%)(n = 151)a(n = 266)bSurgical Risk (%)(n = 156)a(n = 270)bRRR (%)Absolute Risk Difference (%; 95% CI)PInteraction Test (P)
    Risk DifferenceRRR
    Ipsilateral strokec
        eGFR <6016.011.031.25.0 (−2.8 to 12.8)0.340.920.94
        eGFR ≥6013.69.133.14.5 (−1.0 to 9.9)0.15
    Death (any cause)
        eGFR <6010.710.42.80.3 (−6.7 to 7.3)0.990.890.88
        eGFR ≥605.15.3−3.9−0.2 (−4.1 to 3.6)0.88
    Any stroke, MI, or vascular death
        eGFR <6029.919.734.110.2 (−1.3 to 18.4)0.080.260.35
        eGFR ≥6021.518.215.33.3 (−2.7 to 11.1)0.45
    • Medical and surgical groups were compared using a log-rank test. RRR, Relative Risk Reduction.

    • ↵aeGFR <60 ml/min per 1.73 m2.

    • ↵beGFR ≥60 ml/min per 1.73 m2

    • ↵cTo provide a more conservative estimate of the benefits of endarterectomy, the outcome “ipsilateral stroke” includes any stroke and any death within 32 d of randomization (30 d postoperatively; median time from randomization to surgery was 2 d).

    • View popup
    Table 4.

    30-Day perioperative risks of outcomes by CKD status (eGFR, ml/min per 1.73 m2) for patients assigned to carotid endarterectomy (n = 744)

    ParametereGFR <60 (%; n = 245)eGFR ≥60 (%; n = 499)Risk Difference (%; 95% CI)P
    Any stroke or death6.96.40.5 (−3.3 to 4.4)0.79
    Any nonfatal stroke4.95.6−0.7 (−4.1 to 2.7)0.68
    Death (any cause)2.00.81.2 (−0.7 to 3.2)0.15
    MI, CHF, or arrhythmia6.51.25.3 (2.1 to 8.6)<0.001
    MI2.00.61.4 (−0.5 to 3.3)0.07
    CHF1.60.21.4 (−0.2 to 3.1)0.025
    Arrhythmia3.60.63.0 (0.6 to 5.5)0.002
    • Includes patients who had moderate and severe stenoses at time of randomization and actually had surgery. Patients with and without CKD were compared using a χ2 test.

    • View popup
    Table 5.

    30-Day perioperative unadjusted and adjusted risk ratios for patients assigned to carotid endarterectomy (n = 744) with CKD compared to those without CKD

    ParameterUnadjusted Risk Ratio (95% CI)PAdjusted Risk Ratio (95% CI)P
    Any stroke or death1.08 (0.61 to 1.90)0.791.30 (0.73 to 2.33)0.37
    Any nonfatal stroke0.87 (0.45 to 1.69)0.681.09 (0.54 to 2.20)0.81
    Death (any cause)2.55 (0.69 to 9.40)0.162.67 (0.91 to 7.84)0.07
    MI, CHF, or arrhythmia5.43 (2.15 to 13.71)<0.0013.98 (1.60 to 9.90)0.003
    MI3.39 (0.82 to 14.09)0.093.14 (0.81 to 12.23)0.10
    CHF8.14 (0.92 to 72.4)0.065.82 (0.77 to 44.07)0.09
    Arrhythmia6.11 (1.67 to 22.37)0.0063.99 (1.17 to 13.65)0.027
    • Includes patients who had moderate and severe stenoses at time of randomization and actually had surgery. Patients with and without CKD were compared using log-binomial regression. Patients without CKD served as the referent group. Risk ratios were adjusted for age, gender, and a history of hypertension, MI, or smoking.

Additional Files

  • Figures
  • Tables
  • Benefit of Carotid Endarterectomy in Patients with Chronic Kidney Disease

    Files in this Data Supplement:

    • Supplemental Data
  • Benefit of Carotid Endarterectomy in Patients with Chronic Kidney Disease

    Files in this Data Supplement:

    • Press Release
PreviousNext
Back to top

In this issue

Journal of the American Society of Nephrology: 21 (1)
Journal of the American Society of Nephrology
Vol. 21, Issue 1
1 Jan 2010
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
Carotid Endarterectomy Benefits Patients with CKD and Symptomatic High-Grade Stenosis
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Carotid Endarterectomy Benefits Patients with CKD and Symptomatic High-Grade Stenosis
Anna Mathew, Michael Eliasziw, P.J. Devereaux, Jose G. Merino, Henry J.M. Barnett, Amit X. Garg, for the North American Symptomatic Carotid Endarterectomy Trial (NASCET) Collaborators
JASN Jan 2010, 21 (1) 145-152; DOI: 10.1681/ASN.2009030287

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Carotid Endarterectomy Benefits Patients with CKD and Symptomatic High-Grade Stenosis
Anna Mathew, Michael Eliasziw, P.J. Devereaux, Jose G. Merino, Henry J.M. Barnett, Amit X. Garg, for the North American Symptomatic Carotid Endarterectomy Trial (NASCET) Collaborators
JASN Jan 2010, 21 (1) 145-152; DOI: 10.1681/ASN.2009030287
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Results
    • Discussion
    • Concise Methods
    • Disclosures
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

  • Association of Multiple Plasma Biomarker Concentrations with Progression of Prevalent Diabetic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study
  • Conventional and Genetic Evidence on the Association between Adiposity and CKD
  • The Relationship between AKI and CKD in Patients with Type 2 Diabetes: An Observational Cohort Study
Show more Clinical Epidemiology

Cited By...

  • Acute Kidney Injury in Patients With Chronic Kidney Disease Undergoing Internal Carotid Artery Stent Implantation
  • Forty Years of Progress in Stroke
  • Management of Symptomatic Carotid Stenosis in Individuals with CKD
  • Google Scholar

Similar Articles

Related Articles

  • Management of Symptomatic Carotid Stenosis in Individuals with CKD
  • PubMed
  • Google Scholar

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire